Jerome Gilleron

Jerome Gilleron

Auto-generated profile, based on publicly available information

Jerome Gilleron

Université Côte d’Azur, INSERM U1065, Adipo-Cible Research Study Group, Mediterranean Center of Molecular Medicine (C3M), Team “Insulin Resistance in Obesity and Type 2 Diabetes”, Nice, France

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2013 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
JGJerome Gilleron
Jerome Gilleron
WQWilliam Querbes
William Querbes
AZAnja Zeigerer
Anja Zeigerer
ABAnna Borodovsky
Anna Borodovsky
GMGiovanni Marsico
Giovanni Marsico
MZMarino Zerial
Marino Zerial

23 May 2012 in Nature
Verified
Journal Article
Closed access
PDF file
AZAnja Zeigerer
Anja Zeigerer
JGJerome Gilleron
Jerome Gilleron
RBRoman L. Bogorad
Roman L. Bogorad
GMGiovanni Marsico
Giovanni Marsico
HNHidenori Nonaka
Hidenori Nonaka
MZMarino Zerial
Marino Zerial

16 August 2008 in Autophagy
Verified
Journal Article
Open access
NPNicolas Pallet
Nicolas Pallet
NBNicolas Bouvier
Nicolas Bouvier
CLChristophe Legendre
Christophe Legendre
JGJerome Gilleron
Jerome Gilleron
PCPatrice Codogno
Patrice Codogno
DADany Anglicheau
Dany Anglicheau
A major side effect of the powerful immunosuppressive drug cyclosporine (CsA) is the development of a chronic nephrotoxicity whose mechanisms are not fully understood. Recent data suggest that tubu...

7 July 2016 in Diabetes
Verified
Journal Article
Open access
PDF file
BVBastien Vergoni
Bastien Vergoni
PCPierre-Jean Cornejo
Pierre-Jean Cornejo
JGJérôme Gilleron
Jérôme Gilleron
MDMansour Djedaini
Mansour Djedaini
FCFranck Ceppo
Franck Ceppo
MCMireille Cormont
Mireille Cormont
Activation of the p53 pathway in adipose tissue contributes to insulin resistance associated with obesity. However, the mechanisms of p53 activation and the effect on adipocyte functions are still elusive. Here we found a higher level of DNA oxidation and a reduction in telomere length in adipose tissue of mice fed a high-fat diet and an increase in DNA damage and activation of the p53 pathway in adipocytes. Interestingly, hallmarks of chronic DNA damage are visible at the onset of obesity. Furthermore, injection of lean mice with doxorubicin, a DNA damage-inducing drug, increased the expression of chemokines in adipose tissue and promoted its infiltration by proinflammatory macrophages and neutrophils together with adipocyte insulin resistance. In vitro, DNA damage in adipocytes increased the expression of chemokines and triggered the production of chemotactic factors for macrophages and neutrophils. Insulin signaling and effect on glucose uptake and Glut4 translocation were decreased, and lipolysis was increased. These events were prevented by p53 inhibition, whereas its activation by nutlin-3 reproduced the DNA damage-induced adverse effects. This study reveals that DNA damage in obese adipocytes could trigger p53-dependent signals involved in alteration of adipocyte metabolism and secretory function leading to adipose tissue inflammation, adipocyte dysfunction, and insulin resistance.

1 October 2010 in Developmental Biology
Verified
Journal Article
Closed access
DCDiane Carette
Diane Carette
KWKarola Weider
Karola Weider
JGJérome Gilleron
Jérome Gilleron
SGSarah Giese
Sarah Giese
JDJim Dompierre
Jim Dompierre
GPGeorges Pointis
Georges Pointis

5 July 2006 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
JGJerome Gilleron
Jerome Gilleron
MNMarielle Nebout
Marielle Nebout
LSLinda Scarabelli
Linda Scarabelli
FSFrancoise Senegas‐Balas
Francoise Senegas‐Balas
SPSilvio Palmero
Silvio Palmero
GPGeorges Pointis
Georges Pointis